Literature DB >> 17022376

Optimal duration of treatment in surgical patients with calf venous thrombosis involving one or more veins.

Filippo Ferrara1, Francesco Meli, Corrado Amato, Valentina Cospite, Francesco Raimondi, Giuseppe Novo, Salvatore Novo.   

Abstract

The aim of this study was to evaluate different durations of treatment in patients with calf venous thrombosis (CVT) involving 1 or more deep veins. The authors studied 2 groups of patients with postsurgical CVT diagnosed by echo-color Doppler. The first group consisted of 68 patients with CVT involving a single vein, and the second group consisted of 124 patients with CVT involving 2 or more veins. Immediately after diagnosis, all patients were treated with nadroparin calcium and sodium warfarin. Heparin treatment was withdrawn after 5-6 days of treatment, when the international normalized ratio (INR) was stabilized between 2 and 3. Each group was divided into 2 subgroups receiving anticoagulation treatment for 6 or 12 weeks, respectively. The endpoint was proximal extension of the thrombotic lesion, defined as the extension of the thrombus to the popliteal and/or femoral vein. In patients with single-vessel CVT there was no significant difference between the 2 subgroups, whereas in patients with CVT involving 2 or more vessels, a statistically significant difference was observed, the number of cases showing proximal extension of the thrombus being higher among patients treated for 6 weeks. Twelve weeks of anticoagulation treatment is better than 6 weeks only in patients with postsurgical CVT involving 2 or more veins.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17022376     DOI: 10.1177/0003319706290745

Source DB:  PubMed          Journal:  Angiology        ISSN: 0003-3197            Impact factor:   3.619


  6 in total

1.  Joint Guideline on Venous Thromboembolism - 2022.

Authors:  Ana Cristina Lopes Albricker; Cláudia Maria Vilas Freire; Simone Nascimento Dos Santos; Monica Luiza de Alcantara; Mohamed Hassan Saleh; Armando Luis Cantisano; José Aldo Ribeiro Teodoro; Carmen Lucia Lascasas Porto; Salomon Israel do Amaral; Orlando Carlos Gloria Veloso; Ana Cláudia Gomes Pereira Petisco; Fanilda Souto Barros; Márcio Vinícius Lins de Barros; Adriano José de Souza; Marcone Lima Sobreira; Robson Barbosa de Miranda; Domingos de Moraes; Carlos Gustavo Yuji Verrastro; Alexandre Dias Mançano; Ronaldo de Souza Leão Lima; Valdair Francisco Muglia; Cristina Sebastião Matushita; Rafael Willain Lopes; Artur Martins Novaes Coutinho; Diego Bromfman Pianta; Alair Augusto Sarmet Moreira Damas Dos Santos; Bruno de Lima Naves; Marcelo Luiz Campos Vieira; Carlos Eduardo Rochitte
Journal:  Arq Bras Cardiol       Date:  2022-04       Impact factor: 2.000

2.  Outcomes of isolated distal thrombosis managed with serial compression ultrasonography.

Authors:  Alexandra C Brewster; Aubrey E Jones; Stacy A Johnson; John A Saunders; Daniel M Witt
Journal:  Thromb Res       Date:  2021-10-21       Impact factor: 10.407

Review 3.  Treatment of Isolated Below the Knee Deep Vein Thrombosis.

Authors:  Gualtiero Palareti; Michelangelo Sartori
Journal:  Curr Atheroscler Rep       Date:  2016-07       Impact factor: 5.113

4.  Treatment of distal deep vein thrombosis.

Authors:  George Kirkilesis; Stavros K Kakkos; Colin Bicknell; Safa Salim; Kyriaki Kakavia
Journal:  Cochrane Database Syst Rev       Date:  2020-04-09

5.  Pulsatility Index of Popliteal Artery in Patients with Isolated Calf Vein Thrombosis: A Novel Technique for Detecting Thrombosis.

Authors:  Abdussamet Batur; Vural Polat; Mesut Ozgokce; Muhammed Alpaslan; Alpaslan Yavuz; Harun Arslan; Aydin Bora; Mehmet Emin Sakarya
Journal:  Pol J Radiol       Date:  2017-03-22

Review 6.  Duration of treatment with vitamin K antagonists in symptomatic venous thromboembolism.

Authors:  Saskia Middeldorp; Martin H Prins; Barbara A Hutten
Journal:  Cochrane Database Syst Rev       Date:  2014-08-05
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.